Skip to content

Arcutis Biotherapeutics, Inc. ARQT Other Income (Expense)

Other Income (Expense) at other companies

Amgen logo
AmgenAMGN
$75M-95.1%
Incyte logo
IncyteINCY
$2.77M-65.7%
Organon logo
OrganonOGN
-$7M-275%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$14.92M+68.7%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$41.63M-198%
LQD
Liquidia CorporationLQDA
-$4.72M-60.5%

Segments

By segment

See full
Reportable Segment-$20K-110%

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Gross profit$95.6M+67.7%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.28B+57.5%
Enterprise value$3.36B+57.0%
P/S7.9×-1.9×

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s other income (expense)?
Arcutis Biotherapeutics, Inc. (ARQT) reported other income (expense) of -$20K in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s other income (expense) changed year-over-year?
Arcutis Biotherapeutics, Inc.'s other income (expense) decreased by 110.4% year-over-year, from $193K to -$20K.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.